Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL

Published:2019-04 Issue:2 Volume:17 Page:190-200
ISSN:1672-0229
Container-title:Genomics, Proteomics & Bioinformatics
language:en
Short-container-title:Genomics, Proteomics & Bioinformatics

Author:

Zhang Qiong^ORCID,Hu Hui^ORCID,Chen Si-Yi^ORCID,Liu Chun-Jie^ORCID,Hu Fei-Fei,Yu Jianming^ORCID,Wu Yaohui^ORCID,Guo An-Yuan^ORCID

Funder

National Natural Science Foundation of China

National Key R&D Program of China

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Computational Mathematics,Genetics,Molecular Biology,Biochemistry

Reference40 articles.

1. Acute lymphoblastic leukaemia;Inaba;Lancet,2013

2. Chimeric antigen receptor (CAR) T cell therapy for malignant cancers: summary and perspective;Smith;J Cell Immunother,2016

3. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013

4. New development in CAR-T cell therapy;Wang;J Hematol Oncol,2017

5. Toxicity and management in CAR T-cell therapy;Bonifant;Mol Ther Oncolytics,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient’s age, and tumor types;BMC Cancer;2024-08-22

2. Identification and Validation of STC1 Act as a Biomarker for High-Altitude Diseases and Its Pan-Cancer Analysis;International Journal of Molecular Sciences;2024-08-21

3. Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers;Experimental Hematology & Oncology;2024-07-26

4. Single-cell analysis of the survival mechanisms of fratricidal CAR-T targeting of T cell malignancies;Molecular Therapy - Nucleic Acids;2024-06

5. Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review;Critical Reviews in Oncology/Hematology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3